INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | +50.0% | 154 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $2 | 0.0% | 154 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2 | 0.0% | 154 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $2 | -99.9% | 154 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $2,000 | 0.0% | 154 | 0.0% | 0.00% | +50.0% |
| Q2 2022 | $2,000 | -33.3% | 154 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $3,000 | 0.0% | 154 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | +50.0% | 154 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $2,000 | -33.3% | 154 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $3,000 | -25.0% | 154 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | 0.0% | 154 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | -33.3% | 154 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $6,000 | -14.3% | 154 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $7,000 | -30.0% | 154 | 0.0% | 0.01% | -40.0% |
| Q1 2020 | $10,000 | -47.4% | 154 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $19,000 | +90.0% | 154 | 0.0% | 0.02% | +87.5% |
| Q3 2019 | $10,000 | -16.7% | 154 | 0.0% | 0.01% | -11.1% |
| Q2 2019 | $12,000 | -29.4% | 154 | 0.0% | 0.01% | -35.7% |
| Q1 2019 | $17,000 | +6.2% | 154 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $16,000 | -15.8% | 154 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $19,000 | – | 154 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |